Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study. Chest 2020 Sep;158(3):1172-1175
Date
04/01/2020Pubmed ID
32224075Pubmed Central ID
PMC7478227DOI
10.1016/j.chest.2020.03.024Scopus ID
2-s2.0-85088362878 (requires institutional sign-in at Scopus site) 7 CitationsAuthor List
Dhakal B, Rein L, Szabo A, Padmanabhan AAuthors
Binod Dhakal MD Associate Professor in the Medicine department at Medical College of WisconsinLisa E. Rein Biostatistician III in the Data Science Institute department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Data Science Institute department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdolescentAdult
Aged
Anticoagulants
Female
Heparin
Humans
Immunoglobulin G
Immunoglobulins, Intravenous
Male
Middle Aged
Thrombocytopenia
Thrombosis